Traditional Chinese medicine composition for treating idiopathic pulmonary fibrosis and preparation method thereof

Abstract

The invention provides a traditional Chinese medicine composition for treating idiopathic pulmonary fibrosis and a preparation method thereof. The traditional Chinese medicine composition comprises, by weight, 13-23 parts of red sage root, 7-17 parts of bulb of fritillary, 4-14 parts of peach seed, 4-14 parts of ligusticum wallichii, 1-11 parts of lumbricus, 7-17 parts of balloonflower root, 13-23 parts of milkvetch root, 7-17 parts of pilose asiabell root, 4-14 parts of fructus psoraleae, 7-17 parts of tuber of dwarf lilyturf and 4-14 parts of Chinese magnoliavine fruit. The traditional Chinese medicine composition effectively treats idiopathic pulmonary fibrosis, is safe and stable, obviously improves human body immunity, especially improve respiratory system immunity, has effects of promoting blood circulation to remove blood stasis, reducing phlegm and dredging collaterals, and tonifying lung, spleen and kidney, relieves disease pain and prolongs a human life.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, and in particular relates to a traditional Chinese medicine composition for treating idiopathic pulmonary fibrosis and a preparation method thereof. Background technique [0002] Idiopathic pulmonary fibrosis refers to a type of idiopathic interstitial pneumonia that pathologically manifests as usual interstitial pneumonia, and is the most common in idiopathic interstitial pneumonia, accounting for 47%-71%. The lesions are limited to the lungs, causing diffuse pulmonary fibrosis, clinically manifested as progressive exertional shortness of breath, restrictive ventilatory dysfunction with reduced diffusing capacity, hypoxemia, and diffuse lesions in both lungs on imaging. The course of the disease usually progresses slowly, with gradual loss of alveolar-capillary functional units, and eventually develops into diffuse pulmonary fibrosis and honeycombing, leading to respiratory failure an...

AI Technical Summary

Problems solved by technology

However, the drugs currently widely used to treat various fibrosis, including various specific cytokine antagonists involved in the occurrence of fibrosis, and therapeutic monoclonal antibodies, cannot effectively prevent the development of fibrosis, let alone reduce tissue fibrosis. disease mortality

[0006] So far, although there is no unified understanding of the syndrome differentiation and classification of pulmonary fibrosis in the academic circle of traditional Chinese medicine

Images